JPRN-UMIN000014193已完成未知
Effect of phosphodiesterase inhibitor in patients with sinobronchial syndrome - Effect of PDE in SBS
Toyama City Hospital Respiratory Medicine0 个研究点目标入组 20 人开始时间: 2014年6月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional,observational
入排标准
- 年龄范围
- 16years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •patients with active and uncontrolled infection
研究者
相似试验
进行中（未招募）
1 期
Phosphodiesterase-type 5 inhibitors in adult and adolescent patients with univentricular heart disease: a multi-center, randomized, double blind phase III studyEUCTR2018-004828-11-FRniversity Hospital of Montpellier50
暂停
不适用
Effect of phosphodiesterase-3 inhibition with pimobendan on exercise capacity in heart failure with preserved left ventricular ejection fractioHFpEF (heart failure with preserved ejection fraction) with RV-PA uncouplingJPRN-jRCTs051210187Sakata Yasushi88
进行中（未招募）
1 期
Efficacy of Tadalafil on the size and function of the right heart ventriclein adults with a congenital heart disease, whose right ventricle insteadof the left venrticle pumps blood in the body's circulation system.Adults with congenital heart disease (CHD) and a right ventricle (RV) insubaortic (systemic) position.EUCTR2016-004291-21-ATInsel Gruppe AG - Inselspital Universitätsklinik für Kardiologie98
已完成
3 期
Effect of Phosphodiesterase-5 Inhibition With Tadalafil on SystEmic Right VEntricular Size and FunctionHeart Defects, CongenitalTransposition of Great Vessels With Ventricular InversionNCT03049540Insel Gruppe AG, University Hospital Bern100
进行中（未招募）
1 期
ong term effects of DPP-IV inhibitor treatment on the secretion and action of the incretin hormones in patients with type 2 diabetesEUCTR2006-002950-32-DKGentofte University Hospital48